-
FDA’s Approval Of Antibiotic Drug Ketek Under Scrutiny
WSJ Investigative Article Revealed Faulty Data And Improper Record-keeping For Key Drug Study As reported in a May 2, 2006 article by Wall Street Journal reporter Anna Wilde Mathews, Senator Charles Grassley (R-Ill.) as…
-
Phenergan And Similar Drugs Associated With Infant Deaths
FDA Cautions That These Drugs Should Not Be Given To Children Under Two On April 25, 2006 the FDA issued a drug safety alert about promethazine hydrochloride, warning doctors and parents that drugs containing…
-
Antibiotic Tequin Should Be Banned By FDA, Says Public Citizen Petition
Tequin Ban Is Needed To Prevent Any Further Use Of This Unsafe Drug On May 1, 2006 the consumer advocacy group Public Citizen asked the FDA to ban Tequin, an antibiotic made by Bristol-Myers…
-
Bristol-Myers Squibb To Stop Selling Antibiotic Drug Tequin
BMS Action Follows Reports Of Serious Blood-Sugar Problems And Recent Warning Label Changes An April 27, 2006 article by Peter Loftus for Dow Jones Newswires broke the news that Bristol-Myers Squibb Co. has decided…
-
Celebrex Ads Return Despite Continuing Heart Risk Controversy
Celebrex DTC Advertising Was Suspended By Pfizer During 2005 At Request Of FDA Some people may have noticed recently that Pfizer Inc. is advertising its blockbuster drug Celebrex, again, in full-page color ads appearing…
-
GAO Report Says FDA’s Postmarket Drug-Safety Monitoring Is Not Effective
FDA Fails To Timely Detect Emerging Unsafe Drugs Because Of Agency Flaws And Limitations A Government Accountability Office (GAO) report released on April 24, 2006 reached the conclusion that the FDA "lacks a clear…
